CLINICAL_TRIALS
trial_result
· 2025-05-09
Clinical Trial Update: Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003) [Phase 2]
Summary
Phase 2 trial evaluating safety and immunogenicity of three potencies of the V181 dengue vaccine in adults; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Dengue Disease, Dengue Virus | Phase 2 | Status: COMPLETED | Results posted: 2025-05-09